By G R Capital Management LLC
This is a question more medical billing and RCM business owners are beginning to ask: should I consider selling before AI fully reshapes the market? There is no one-size-fits-all answer — but the question itself is worth taking seriously.
Two Reasonable Paths
For some owners, the answer may be yes — pursue a sale now while the business looks favorable to buyers. For others, the better move may be to improve the business, adopt better tools, strengthen reporting, and prepare for a more valuable exit later.
The right path depends on where the company stands today and where it could reasonably stand in a few years.
The Factors That Drive the Decision
- How dependent is the company on the owner?
- How manual are the workflows?
- How strong is client retention?
- How concentrated is revenue?
- How clean are the financials?
- How well does the company track performance?
- Is the business growing, flat, or declining?
- Can the company prove its value to clients?
- Has management started adopting automation or AI-supported workflows?
Why AI May Widen the Valuation Gap
A well-run company with strong client relationships, specialty expertise, measurable KPIs, low concentration, and a credible technology roadmap may continue to attract buyer interest.
A company that is highly manual, owner-dependent, light on reporting, and unable to show performance data may face more scrutiny — and increasingly, more discounting at the negotiation table.
When It May Be Worth Evaluating Options Now
For owners who are within a few years of retirement, or who are unsure about making the next round of technology and management investments, it may be worth evaluating strategic options sooner rather than later.
That does not necessarily mean going to market immediately. It may simply mean understanding:
- what the business may be worth today
- what buyers would likely focus on
- what issues could reduce value
- what improvements could increase value
- whether a sale, recapitalization, or growth plan makes the most sense
Be Proactive, Not Reactive
AI is not the only factor affecting the RCM market — but it is becoming part of the conversation. For owners, the key is to be proactive rather than reactive.
The best time to understand your options is before you are forced to make a decision.
Considering the Future of Your RCM or Medical Billing Company?
If you own a revenue cycle management or medical billing business and would like to better understand how market changes, AI adoption, buyer expectations, and valuation trends may affect your company, G R Capital Management can help you evaluate your options.
Contact G R Capital Management for a confidential conversation.
